BBR inhibits the malignant behavior of colorectal cancer by targeting AMPK or the TGF-β1/Smad signaling pathway (9, 10), blocking the cell cycle, promoting the apoptosis of colorectal cancer cells, and inhibiting growth factor signaling pathways (11, 12). The gene discussed is TGFB1; the disease is colorectal cancer.